Matthew Bucknor

MD

Radiologist
Writer, musician and kamado grill enthusiast

Dr. Matthew Bucknor is a radiologist who diagnoses and treats diseases and injuries of the musculoskeletal system. Guided by imaging technologies including X-ray, ultrasound, CT and MRI, he performs procedures such as injections, tissue sampling and focal tumor treatments (a noninvasive technique for treating small tumors using energy sources).

Bucknor's research focuses on developing magnetic resonance–guided focused ultrasound, a noninvasive method for treating tumors using sound waves. He oversees UCSF clinical trials that evaluate ways to use this technology for various conditions.

Bucknor earned his medical degree from Stanford University School of Medicine. He completed a residency in radiology at UCSF and a fellowship in musculoskeletal imaging and intervention at Stanford.

Honoring his commitment to promoting diversity, inclusion and health equity in medicine, UCSF named Bucknor a John A. Watson Faculty Scholar and awarded him the Chancellor Award for Dr. Martin Luther King Jr. Leadership.

  • Education

    Stanford University School of Medicine, 2008

  • Residencies

    UCSF, Radiology, 2013

  • Fellowships

    Stanford Medicine, Musculoskeletal Imaging and Intervention, 2014

  • Academic Title

    Associate Professor

I advocate tirelessly for all of my patients – both those whom I have the privilege of directly treating and those I may never meet face to face.

Where I see patients (6)

    Selected research

    See all research
    Decorative Caduceus

    A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the...

    The statistical hypothesis is that the proportion of responders will be significantly greater than the proportion of subjects experiencing pain progression (worsened pain or increased pain medications usage) by at least 30% or an ...

    Recruiting

    Decorative Caduceus

    Focused Ultrasound to Promote Immune Responses for Undifferentiated Pleomorphic Sarcoma

    Proportion of participants with device-related adverse events will be determined by evaluating the incidence and severity of any device-related complications from the treatment day visit through the time of surgery or last post-tr...

    Recruiting

    Decorative Caduceus

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

    1 month after treatment, worst VAS score over the last 24 hours will be assessed

    Recruiting

    Contact me

    Providers on my team

    Share